Patricia Calderón Lloyd1, Larissa May, Daniel Hoffman, Richard Riegelman, Lone Simonsen. 1. From the *Department of Epidemiology and Biostatistics, The George Washington University School of Public Health and Health Services; †Department of Emergency Medicine, The George Washington University Medical Faculty Associates; and ‡Department of Global Health, The George Washington University School of Public Health and Health Services, Washington, DC.
Abstract
BACKGROUND: Respiratory syncytial virus (RSV) is the most common cause of severe respiratory illness in infants. To help direct targeted interventions and future RSV vaccine programs, we examined risk of RSV-related hospitalization by infant age and birth month. METHODS: We conducted Poisson regression analyses to evaluate birth month as a risk factor for RSV-related pediatric hospitalizations (identified by any mention of ICD-9-CM diagnosis codes: 466.11, 480.1 or 079.6) from State Inpatient Data in Arizona, Iowa, New York, Oregon and Wisconsin between July 1996 and June 2006. We used an age cohort approach to compute total relative risk of RSV during the first year of life. RESULTS: We identified 82,296 RSV-related infant hospital admissions, corresponding to 13.9 per 1000 person-years among infants <12 months of age. Of these, 42% of the patients were female and 73% were <6 months old. One-month-old infants born in January were ~10 times more at risk for RSV-related hospitalization than 1-month-old infants born in October [relative risk: 9.8 (7.8-12.4)]. Across the first year of life, infants born in December and January had a 2- and 3-fold higher risk, respectively, of an RSV-related hospitalization event than infants born in July. CONCLUSIONS: Birth month and age at admission impacted the risk of RSV-related hospitalization within the first year of life in 5 states we investigated. As RSV vaccine candidates are currently under investigation in clinical trials, our findings help identify ideal RSV vaccine schedules to prevent early and severe events while improving the use of expensive prophylactic drugs.
BACKGROUND:Respiratory syncytial virus (RSV) is the most common cause of severe respiratory illness in infants. To help direct targeted interventions and future RSV vaccine programs, we examined risk of RSV-related hospitalization by infant age and birth month. METHODS: We conducted Poisson regression analyses to evaluate birth month as a risk factor for RSV-related pediatric hospitalizations (identified by any mention of ICD-9-CM diagnosis codes: 466.11, 480.1 or 079.6) from State Inpatient Data in Arizona, Iowa, New York, Oregon and Wisconsin between July 1996 and June 2006. We used an age cohort approach to compute total relative risk of RSV during the first year of life. RESULTS: We identified 82,296 RSV-related infant hospital admissions, corresponding to 13.9 per 1000 person-years among infants <12 months of age. Of these, 42% of the patients were female and 73% were <6 months old. One-month-old infants born in January were ~10 times more at risk for RSV-related hospitalization than 1-month-old infants born in October [relative risk: 9.8 (7.8-12.4)]. Across the first year of life, infants born in December and January had a 2- and 3-fold higher risk, respectively, of an RSV-related hospitalization event than infants born in July. CONCLUSIONS:Birth month and age at admission impacted the risk of RSV-related hospitalization within the first year of life in 5 states we investigated. As RSV vaccine candidates are currently under investigation in clinical trials, our findings help identify ideal RSV vaccine schedules to prevent early and severe events while improving the use of expensive prophylactic drugs.
Authors: David T Siefker; Luan Vu; Dahui You; Andrew McBride; Ryleigh Taylor; Tamekia L Jones; John DeVincenzo; Stephania A Cormier Journal: Am J Respir Crit Care Med Date: 2020-02-01 Impact factor: 21.405
Authors: Gonçalo Matias; Robert Taylor; François Haguinet; Cynthia Schuck-Paim; Roger Lustig; Vivek Shinde Journal: BMC Public Health Date: 2017-03-21 Impact factor: 3.295
Authors: Richard Thwaites; Scot Buchan; John Fullarton; Carole Morris; ElizaBeth Grubb; Barry Rodgers-Gray; Jonathan Coutts Journal: Eur J Pediatr Date: 2020-01-07 Impact factor: 3.183
Authors: C Demont; N Petrica; I Bardoulat; S Duret; L Watier; A Chosidow; M Lorrot; A Kieffer; M Lemaitre Journal: BMC Infect Dis Date: 2021-08-02 Impact factor: 3.090
Authors: John M McLaughlin; Farid Khan; Heinz-Josef Schmitt; Yasmeen Agosti; Luis Jodar; Eric A F Simões; David L Swerdlow Journal: J Infect Dis Date: 2022-03-15 Impact factor: 5.226